Among MDS patients with IDH1/2 mutations, two (18.18%) were classified as RAEB1, seven (63.64%) as RAEB2 and two (18.18%) as RCMD. Here, IDH1 is linked to myelodysplastic syndrome with multilineage dysplasia.